(2026). Cerebrospinal fluid NPTX2/p‐tau ratio as a biomarker for cognitive decline in neurodegenerative diseases. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Cerebrospinal Fluid NPTX2/p‐tau Ratio as a Biomarker for Cognitive Decline in Neurodegenerative Diseases."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Cerebrospinal Fluid NPTX2/p‐tau Ratio as a Biomarker for Cognitive Decline in Neurodegenerative Diseases."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.